Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Revenue:
Net revenue - collaboration	$ 161,781		$ 161,781
Net revenue - commercial product sales	573		573
Total net revenue	162,354		162,354
Expense:
Product costs - collaboration	22,742		22,742
Cost of goods sold	4,331	$ 8,115	15,567	$ 15,688
Research and development	3,917	6,341	13,357	23,455
Selling, general and administrative	13,135	11,547	31,595	32,649
Total expenses	44,125	26,003	83,261	71,792
Income (loss) from operations	118,229	(26,003)	79,093	(71,792)
Change in fair value of warrant liability	13,185		7,879
Interest income	28	2	70	8
Interest expense on notes	(4,166)	(4,145)	(12,567)	(17,899)
Interest expense on note payable to our principal stockholder	(729)	(729)	(2,172)	(2,164)
Loss on extinguishment of debt		(1,049)		(1,049)
Other (expense) income	(27)	67	(613)	1,470
Income (loss) before income tax benefit (expense)	126,520	(31,857)	71,690	(91,426)
Income tax benefit (expense)	0	0	0	0
Net income (loss)	$ 126,520	$ (31,857)	$ 71,690	$ (91,426)
Net income (loss) per share - basic	$ 0.26	$ (0.08)	$ 0.16	$ (0.23)
Net income (loss) per share - diluted	$ 0.26	$ (0.08)	$ 0.16	$ (0.23)
Shares used to compute basic net income (loss) per share	478,137	405,199	454,188	401,734
Shares used to compute diluted net income (loss) per share	482,744	405,199	454,366	401,734